Similar articles

• The effect of sibutramine therapy on occurrence of depression symptoms among obese patients.

  Slovacek L, Pavlik V, Slovackova B. Slovacek L, et al. Nutr Metab Cardiovasc Dis. 2008 Oct;18(8):e43-4. doi: 10.1016/j.numecd.2008.04.002. Epub 2008 Aug 3. Nutr Metab Cardiovasc Dis. 2008. PMID: 18676135 No abstract available.
• Drug therapy for obesity: clarifications.

  Seaton TB. Seaton TB. J Am Pharm Assoc (Wash). 1997 Jul-Aug;NS37(4):374. J Am Pharm Assoc (Wash). 1997. PMID: 9519642 No abstract available.
• Long-term medication use and weight loss maintenance: an observational study.

  Womble LG, Wadden TA, Berkowitz RI, Sarwer DB, Rothman RA. Womble LG, et al. Obes Res. 2001 Oct;9(10):652-3. doi: 10.1038/oby.2001.88. Obes Res. 2001. PMID: 11595785 No abstract available.
• Does drug therapy of obesity have a future?

  Trakas K, Leiter L, Shear NH. Trakas K, et al. Can J Clin Pharmacol. 2000 Autumn;7(3):133-4. Can J Clin Pharmacol. 2000. PMID: 11044757 Review. No abstract available.
• The new role of pharmacotherapy for weight reduction in obesity.

  Fernstrom MH, Fernstrom JD. Fernstrom MH, et al. Int J Clin Pract. 2002 Nov;56(9):683-6. Int J Clin Pract. 2002. PMID: 12469983 Review.